Search clinical trials for: DBV712 IHRP

Total 29 results

DBV Technologies

Completed

A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects (V712-103)

Peanut Allergy

United States
DBV Technologies

No longer available

Viaskin® Peanut (DBV712) Expanded Access Protocol

Peanut Allergy
DBV Technologies

Enrolling by invitation

Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children (EPOPEX)

Peanut Allergy

United States
DBV Technologies
Todd D. Green MD, DBV Technologies

Available

Expanded Access Protocol of Viaskin® Peanut (DBV712) in Peanut-allergic Children

Peanut Allergy

United States
National Institute of Allergy and Infectious Diseases...
Consortium of Food Allergy Research

Completed

Peanut Epicutaneous Phase II Immunotherapy Clinical Trial

Hypersensitivity | Food Hypersensitivity | Hypersensitivity, Immediate | Peanut Hypersensitivity

United States
DBV Technologies

Completed

Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy (PEPITES)

Peanut Allergy

United States, Canada, Germany, Australia, Ireland
DBV Technologies

Recruiting

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age (VITESSE)

Allergy, Peanut

United States, Canada, France, Germany, Ireland, Netherlands, Spain, United Kingdom, Australia
DBV Technologies

Completed

Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy

Peanut Allergy

United States
University of Connecticut

Completed

Adapting a Behavioral Intervention to Accommodate Cognitive Dysfunction in People Who Inject Drugs

Cognitive Dysfunction

United States
QLT Inc.

Terminated

A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis

End Stage Renal Disease

United States
Iconacy Orthopedic Implants, LLC.

Unknown

Multi-Site, Post-Market Study of the ICONACY I-Hip System

Degenerative Joint Disease

United States
University of Calgary

Recruiting

IPRP Repeated Transcranial Magnetic Stimulation (rTMS)

Chronic Pain

Canada
Daewoong Pharmaceutical Co. LTD.

Completed

Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines

Glabellar Lines

Korea, Republic of
Vastra Gotaland Region
Karolinska University Hospital; Rigshospitalet, Denmark; University Hospital,... and other collaborators

Completed

The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver Metastases (SCANDIUM)

Melanoma | Uveal Neoplasms

Sweden
Mary Free Bed Rehabilitation Hospital

Completed

Dual Treatment of Chronic Pain and Insomnia

Chronic Pain | Insomnia

United States
Linkoeping University

Active, not recruiting

Guided Internet-delivered Psychological Treatment for Chronic Pain (MERIT)

Chronic Pain
Iconacy Orthopedic Implants, LLC.

Withdrawn

Post-Market Study of the ICONACY Hip System

Degenerative Joint Disease
RenJi Hospital

Completed

Pericoronary Fat Attenuation Index and High-risk Plaque in Patients With Acute Coronary Syndrome

Acute Coronary Syndrome

China
Hospital Universitario Araba
University of Chicago; ResMed; Hospital de Basurto; Instituto de Salud Carlos III; Hospital Universitario 12 de Octubre and other collaborators

Completed

Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea in Children (DINISAS) (DINISAS)

Obstructive Sleep Apnea

Spain
Western University, Canada
Public Health Agency of Canada (PHAC)

Completed

Evaluation of the Healthy Relationships Program for 2SLGBTQIA+ Youth

Adolescent Development

Canada
University of Connecticut
National Institute on Drug Abuse (NIDA); APT Foundation, Inc.

Completed

Testing an Integrated Bio-Behavioral Primary HIV Prevention Intervention Among High-Risk People Who Use Drugs (CHRP-BB)

Risk Behavior | HIV/AIDS | Medication Adherence | Substance Abuse

United States
University of Erlangen-Nürnberg Medical School
ADAC (The General German Automobile Club) foundation

Completed

Safer Cycling In Older Age (SiFAr)

Older Adults | Community-dwelling | Cycling Competence

Germany
Tulane University Health Sciences Center

Withdrawn

Effect of Continuous GHRP-3 Infusion at on GH-IGF-I System, Blood Pressure, Glucose, and Insulin Resistance

Insulin Resistance | Endothelial Dysfunction
NYU Langone Health
National Institute of General Medical Sciences (NIGMS)

Not yet recruiting

Harm Reduction Services (HRS)

Mental Illness | Substance Abuse | Drug Use

United States
University of Connecticut

Recruiting

Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP (MOST)

Hiv | Opioid Use Disorder

United States
University of Connecticut
National Institute on Drug Abuse (NIDA); APT Foundation, Inc.

Completed

Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users

HIV | Opioid Dependence

United States
University of Connecticut
National Institute on Drug Abuse (NIDA); Yale University; APT Foundation, Inc.

Completed

Secondary HIV Prevention and Adherence Among HIV-infected Drug Users

Risk Behavior | HIV | Medication Adherence

United States
Satish R. Raj
National Institutes of Health (NIH)

Recruiting

Pathophysiology of Orthostatic Intolerance

Tachycardia | Postural Orthostatic Tachycardia Syndrome

United States
Maastricht University Medical Center

Completed

Increasing Ferulic Acid Bioavailability in Bran

Healthy Males

Netherlands

Search clinical trials for: DBV712 IHRP

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations